Companies that report earnings and guidance above market expectations typically see a positive reaction in their stock price as investors adjust their valuations based on the new information. Charles River Laboratories' announcement of exceeding Q4 expectations and providing guidance above estimates directly impacts investor sentiment and the perceived value of the company, leading to a likely increase in stock price in the short term.